STAT3 activates the lipoprotein lipase (LPL) gene that shifts the metabolic program of CLL cells towards an abnormal fatty acid oxidation and then to an abundant ROS production into the mitochondria [70]. The gene discussed is LPL; the disease is B-cell chronic lymphocytic leukemia.